Xenon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $28.19-$63.95 |
Market Cap | $5.2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$328.2M |
Diluted EPS | -$4.70 |
News
See moreYahoo Finance • 8 hours ago
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Merck & Co Inc: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund
Yahoo Finance • last month
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
Yahoo Finance • 3 months ago
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
About
CEO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
Address | 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 358 |